Skip to main content
SpringerLink
Log in

Impact of medicines on Public Health: EURO-MED-STAT

  • Chapter
Public Health in Europe

  • 92 Accesses

Abstract

Several thousand medicinal products are presently licensed and marketed in the European Union countries. The overall use of active ingredients is in the order of tons per day and the expenditure more than € 90 billions per year (€ 56 billions of which are paid by national health care systems).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gottlieb S, Congress criticises drug industry for misleading advertising BMJ 2002; 325: 1379

    Article  PubMed  Google Scholar 

  2. Steel K, Gertman PM, Crescenzi C et al. Iatrogenic illness on a general medical service at a university hospital. New Engl J Med 1981; 304:638–642

    Article  PubMed  CAS  Google Scholar 

  3. Bedell SE, Deitz DC, Leeman D, DelBanco TL. Incidence and characteristics of preventable iatrogenic cardiac arrests. JAMA 1991; 265:2815–2820

    Article  PubMed  CAS  Google Scholar 

  4. Brennan TA, Leape LL, Laird NM, Hebert L, Localio R, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH. Incidence of adverse events and negligence in hospitalized patients. Results of The Harvard Medical Practice Study I. New Engl J Med 1991; 324:370–376

    Article  PubMed  CAS  Google Scholar 

  5. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes Ba et al. The nature of adverse events in hospitalized patients. Results of The Harvard Medical Practice Study II. New Engl J Med 1991; 324:377–384

    Article  PubMed  CAS  Google Scholar 

  6. Wilson McLR, Runciman WB, Gibberd RB, Harrison BT, Newby L, Hamilton JD. The quality in Australian Health Care Study. Med J Aust 1995; 163:458–471

    PubMed  CAS  Google Scholar 

  7. American Academy of Pediatrics. Committee on Drugs and Committee on Hospital Care Prevention of Medication Errors in the Pediatric Inpatient Setting. Pediatrics 1998; 102:428–430

    Article  Google Scholar 

  8. European Commission, Enterprise Directorate-General: Better medicines for children. Proposed regulatory actions on paediatric medicinal products. Consultation document Brussels February 28th 2002

    Google Scholar 

  9. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279:1200–1205

    Article  Google Scholar 

  10. Kohn LT, Corrigan JM, Donaldson MS, eds: To err is human: building a safe health system. Washington DC; National Academic Press; 1999

    Google Scholar 

  11. Phillips DP, Christenfeld N, Glynn LN. Increase in US medication-error deaths between 1983 and 1993. Lancet 1998; 351:643–644

    Article  PubMed  CAS  Google Scholar 

  12. Johnson JA, Bootman JL. Drug related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155:1949–1956

    Article  PubMed  CAS  Google Scholar 

  13. Johnson JA, Bootman JL. Drug related morbidity and mortality and the economic impact of pharmaceutical care Am J Health Syst Pharm 1997; 54:554–558

    PubMed  CAS  Google Scholar 

  14. UK Audit Commission A spoonful of sugar London December 2001

    Google Scholar 

  15. Health Council of the Netherlands. Environmental risks of medicines. The Hague: Health Council of the Netherlands 2001 (in Dutch)

    Google Scholar 

  16. United Nations Department for Policy Coordination and Sustainable Development. Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by governments. Sixth issue. New York 1997 United Nations Publications

    Google Scholar 

  17. Buser HR, Muller MD, Theobald N Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North sea Environ Sei Technol 1998; 32:188–192

    Article  CAS  Google Scholar 

  18. Giusti RM, Iwamoto K, Hatch EE Diethylstilbestrol revisited: A review of the long term health effects. Ann Intern Med 1995; 122:778–788

    PubMed  CAS  Google Scholar 

  19. Daughton CG. Environmental stewardship and drugs as pollutants Lancet 2002; 360:1035–1036

    Article  PubMed  Google Scholar 

  20. Zuccato E, Calamari D, Natangelo M, Fanelli R Presence of therapeutic drugs in the environment Lancet 2000; 355:1789–1790

    Article  PubMed  CAS  Google Scholar 

  21. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs Oslo 2002

    Google Scholar 

  22. European Committee for Standardization. European prestandard ENV 12610 Medical informatics-Medicinal product identification. Brussels 1997

    Google Scholar 

  23. N Hammar: Monitoring of acute myocardial infarction and coronary heart disease Eur J Public Health 2002; 12:17–18

    Google Scholar 

  24. Salomaa V. Monitoring of stroke and other cerebrovascular diseases Eur J Public Health 2002; 12:18

    Google Scholar 

  25. S Sans: Monitoring of cardiovascular risk factors Eur J Public Health 2002; 12:18

    Google Scholar 

  26. S Giampaoli: Recommendations from the EUROCISS project Eur J Public Health 2002; 12:18

    Google Scholar 

  27. Folino-Gallo P, Walley T, Frölich JC, Carvajal A, Edwards RI. Availability of medicines in the European Union. Results from the EURO-Medicines project. Eur J Clin Pharmacol 2001; 57:441–446

    Article  PubMed  CAS  Google Scholar 

  28. Cars, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851–1853

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Research on Population and Social Policies, National Research Council of Italy, Via Nizza, 198, 1-00198, Rome, Italy

    Prof. Dr. Pietro Folino-Gallo

  2. Department of Pharmacology and Therapeutics, University of Liverpool, 70 Pembrooke Place, UK-Liverpool, L69 3GF, England

    Dr. Tom Walley

  3. Regional Adviser for Pharmaceuticals and Technology, WHO-Regional Office for Europe, 8, Scherfigsvej, DK-2100, Copenhagen, Denmark

    Dr. Kees DeJoncheere

  4. Heymans Institute of Pharmacology, University of Ghent, De Printelaan 185, B-9000, Ghent, Belgium

    Dr. Robert Vander Stichele

Authors
  1. Prof. Dr. Pietro Folino-Gallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. Tom Walley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. Kees DeJoncheere
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. Robert Vander Stichele
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

EURO-MED-STAT Project

Editor information

Editors and Affiliations

  1. Medical Faculty, Technical University Dresden, Fiedlerstr. 27, D-01307, Dresden, Germany

    Wilhelm Kirch (President European Public Health Association Chairman Public Health Research Association Saxony) (President European Public Health Association Chairman Public Health Research Association Saxony)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Folino-Gallo, P., Walley, T., DeJoncheere, K., Vander Stichele, R., EURO-MED-STAT Project. (2004). Impact of medicines on Public Health: EURO-MED-STAT. In: Kirch, W. (eds) Public Health in Europe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18826-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18826-8_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62311-0

  • Online ISBN: 978-3-642-18826-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation